Clinical expert consensus document on the use of percutaneous left ventricular assist support devices during complex high-risk indicated PCI: Italian Society of …

A Chieffo, F Burzotta, F Pappalardo, C Briguori… - International Journal of …, 2019 - Elsevier
Percutaneous coronary intervention (PCI) is establishing as the last remaining
revascularization option in an increasing number of patients affected by complex coronary …

Long‐Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella‐Protected Percutaneous Coronary Intervention …

F Burzotta, G Russo, F Ribichini… - Journal of …, 2019 - Wiley Online Library
Objective. To investigate the effect of extent of revascularization in complex high‐risk
indicated patients (CHIP) undergoing Impella‐protected percutaneous coronary intervention …

Risk of contrast-induced nephropathy in patients undergoing complex percutaneous coronary intervention

L Azzalini, E Poletti, F Lombardo, A Laricchia… - International Journal of …, 2019 - Elsevier
Background Complex percutaneous coronary intervention (PCI) is associated with
increased procedural challenges and high contrast load. We aimed to evaluate the …

Access site complications following Impella-supported high-risk percutaneous coronary interventions

L Johannsen, AA Mahabadi, M Totzeck, A Krueger… - Scientific Reports, 2019 - nature.com
Mechanical circulatory support (MCS) devices are increasingly used to provide
hemodynamic stability for patients with severe coronary artery disease, comorbidities, and/or …

Comparison of peri and post-procedural complications in patients undergoing revascularisation of coronary artery multivessel disease by coronary artery bypass …

T Becher, S Baumann, F Eder… - … Heart Journal: Acute …, 2019 - academic.oup.com
Background While coronary artery bypass grafting remains the standard treatment of
complex multivessel coronary artery disease, the advent of peripheral ventricular assist …

[HTML][HTML] Protected percutaneous coronary intervention with Impella CP in a patient with left main disease, severe left ventricular systolic dysfunction and established …

K Konstantinou, TR Keeble, PA Kelly… - Cardiovascular …, 2019 - ncbi.nlm.nih.gov
The use of the Impella device in patients with left ventricular (LV) systolic impairment
undergoing left main (LM) percutaneous coronary intervention (PCI) has been growing …

Nonemergent percutaneous coronary intervention on an unprotected left main coronary artery supported with Impella® heart pump in patients ineligible for surgical …

PM Meraj, S Dixon, J Moses, K Ibrahim… - Journal of …, 2019 - Wiley Online Library
Objectives. We sought to assess if ineligibility to coronary artery bypass grafting (CABG)
constitutes a risk factor in patients who underwent a nonemergent unprotected left main …

[PDF][PDF] Clinical expert consensus document on the use of percutaneous left ventricular assist support devices during complex high-risk indicated PCI Italian Society of …

G Esposito, G Tarantini - 2019 - gise.it
Alaide Chieffo a, Francesco Burzotta b, Federico Pappalardo c, Carlo Briguori d, Roberto
Garbo e, Giulia Masiero f, Elisa Nicolini g, Flavio Ribichini h, Carlo Trani b, Belén Cid …

[引用][C] Research Article Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected …

F Burzotta, G Russo, F Ribichini, A Piccoli, D D'Amario… - 2019